Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3074292449;92450;92451 chr2:178549402;178549401;178549400chr2:179414129;179414128;179414127
N2AB2910187526;87527;87528 chr2:178549402;178549401;178549400chr2:179414129;179414128;179414127
N2A2817484745;84746;84747 chr2:178549402;178549401;178549400chr2:179414129;179414128;179414127
N2B2167765254;65255;65256 chr2:178549402;178549401;178549400chr2:179414129;179414128;179414127
Novex-12180265629;65630;65631 chr2:178549402;178549401;178549400chr2:179414129;179414128;179414127
Novex-22186965830;65831;65832 chr2:178549402;178549401;178549400chr2:179414129;179414128;179414127
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: AGG
  • RefSeq wild type template codon: TCC
  • Domain: Fn3-112
  • Domain position: 24
  • Structural Position: 26
  • Q(SASA): 0.5585
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/K rs1698436310 None 0.997 N 0.565 0.298 0.231873229951 gnomAD-4.0.0 3.18285E-06 None None None None N None 0 4.57373E-05 None 0 0 None 0 0 0 0 0
R/W rs1698437169 None 1.0 D 0.788 0.484 0.384252928164 gnomAD-4.0.0 3.18296E-06 None None None None N None 0 0 None 0 0 None 0 0 5.71706E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.4487 ambiguous 0.4494 ambiguous -0.034 Destabilizing 0.999 D 0.639 neutral None None None None N
R/C 0.2084 likely_benign 0.2037 benign -0.391 Destabilizing 1.0 D 0.798 deleterious None None None None N
R/D 0.8059 likely_pathogenic 0.8112 pathogenic -0.422 Destabilizing 1.0 D 0.769 deleterious None None None None N
R/E 0.4558 ambiguous 0.4731 ambiguous -0.312 Destabilizing 0.999 D 0.669 neutral None None None None N
R/F 0.6312 likely_pathogenic 0.6274 pathogenic -0.151 Destabilizing 1.0 D 0.743 deleterious None None None None N
R/G 0.4241 ambiguous 0.4195 ambiguous -0.257 Destabilizing 1.0 D 0.714 prob.delet. N 0.475963914 None None N
R/H 0.1378 likely_benign 0.1328 benign -0.956 Destabilizing 1.0 D 0.766 deleterious None None None None N
R/I 0.3794 ambiguous 0.3759 ambiguous 0.532 Stabilizing 1.0 D 0.763 deleterious None None None None N
R/K 0.1363 likely_benign 0.1319 benign -0.14 Destabilizing 0.997 D 0.565 neutral N 0.496468734 None None N
R/L 0.3065 likely_benign 0.3019 benign 0.532 Stabilizing 1.0 D 0.714 prob.delet. None None None None N
R/M 0.3966 ambiguous 0.3969 ambiguous -0.164 Destabilizing 1.0 D 0.755 deleterious N 0.480523044 None None N
R/N 0.7431 likely_pathogenic 0.7429 pathogenic -0.224 Destabilizing 1.0 D 0.783 deleterious None None None None N
R/P 0.3565 ambiguous 0.3663 ambiguous 0.363 Stabilizing 1.0 D 0.759 deleterious None None None None N
R/Q 0.1349 likely_benign 0.1359 benign -0.153 Destabilizing 1.0 D 0.779 deleterious None None None None N
R/S 0.6287 likely_pathogenic 0.6224 pathogenic -0.427 Destabilizing 1.0 D 0.758 deleterious N 0.468290911 None None N
R/T 0.4439 ambiguous 0.4355 ambiguous -0.16 Destabilizing 1.0 D 0.752 deleterious N 0.481217379 None None N
R/V 0.4353 ambiguous 0.4352 ambiguous 0.363 Stabilizing 1.0 D 0.764 deleterious None None None None N
R/W 0.2422 likely_benign 0.2374 benign -0.275 Destabilizing 1.0 D 0.788 deleterious D 0.523555182 None None N
R/Y 0.453 ambiguous 0.4591 ambiguous 0.124 Stabilizing 1.0 D 0.78 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.